News
Videos
Conferences
Events
Resources
Subscribe

|Videos|March 3, 2017

Navigating a Colon Cancer Journey

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Stage 3 colon cancer patients who tested MRD+ with Signatera after surgery saw a meaningful survival benefit from Celebrex and chemo: © stock.adobe.com.

This Test Helped Identify Treatment in Colorectal Cancer Surgery

December 19th 2025

The FDA granted fast track status to muzastotug plus Keytruda for adults with microsatellite stable metastatic colorectal cancer without liver metastases: © stock.adobe.com.

FDA Grants Fast Track Status to Muzastotug for Some Colorectal Cancers

BySpencer Feldman

December 16th 2025

Image of two people.

Experts Highlight Notable Advances in Colorectal Cancer at 2025 ESMO

ByDr. Joshua K. Sabari

November 13th 2025

Image of hands.

I’m Still Here: My Fight Against Colorectal Cancer

ByChrista Messmer

October 28th 2025

The FDA grants fast track status to alnodesertib in mCRC with ATM deficiency: © stock.adobe.com.

Alnodesertib Wins FDA Fast Track Status in ATM-Negative Colorectal Cancer

BySpencer Feldman

September 24th 2025

Trending on CURE

FDA Grants Breakthrough Status to Enhertu for Some HER2+ Early Breast Cancers

What Palliative Care Means for Patients with Metastatic Breast Cancer

Orserdu Combo Shows Potential for ER+/HER2– Breast Cancer

Advice for Patients Newly Diagnosed With Lung Cancer

How Nutrition Impacts Breast Cancer Risk and Recovery